DK436688D0 - Praeparat af anthracyclin og derivater deraf samt fremgangsmaade til fremstilling af dette - Google Patents

Praeparat af anthracyclin og derivater deraf samt fremgangsmaade til fremstilling af dette

Info

Publication number
DK436688D0
DK436688D0 DK436688A DK436688A DK436688D0 DK 436688 D0 DK436688 D0 DK 436688D0 DK 436688 A DK436688 A DK 436688A DK 436688 A DK436688 A DK 436688A DK 436688 D0 DK436688 D0 DK 436688D0
Authority
DK
Denmark
Prior art keywords
anthracyclin
preparations
derivatives
preparing
procedure
Prior art date
Application number
DK436688A
Other languages
English (en)
Other versions
DK436688A (da
DK173317B1 (da
Inventor
Yasuhisa Sakamaki
Yukio Ozaki
Norihiko Tanno
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of DK436688D0 publication Critical patent/DK436688D0/da
Publication of DK436688A publication Critical patent/DK436688A/da
Application granted granted Critical
Publication of DK173317B1 publication Critical patent/DK173317B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK198804366A 1987-08-05 1988-08-04 Stabiliseret præparat af anthracyclinderivat samt fremgangsmåde til fremstilling af dette DK173317B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62197032A JP2603480B2 (ja) 1987-08-05 1987-08-05 安定化されたアンスラサイクリン系製剤
JP19703287 1987-08-05

Publications (3)

Publication Number Publication Date
DK436688D0 true DK436688D0 (da) 1988-08-04
DK436688A DK436688A (da) 1989-02-06
DK173317B1 DK173317B1 (da) 2000-07-17

Family

ID=16367605

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804366A DK173317B1 (da) 1987-08-05 1988-08-04 Stabiliseret præparat af anthracyclinderivat samt fremgangsmåde til fremstilling af dette

Country Status (14)

Country Link
US (1) US4952566A (da)
EP (1) EP0302729B1 (da)
JP (1) JP2603480B2 (da)
KR (1) KR970000507B1 (da)
AT (1) ATE71526T1 (da)
AU (1) AU609168B2 (da)
CA (1) CA1324959C (da)
DE (1) DE3867751D1 (da)
DK (1) DK173317B1 (da)
ES (1) ES2038763T3 (da)
FI (1) FI91483C (da)
GR (1) GR3004330T3 (da)
NO (1) NO175134C (da)
NZ (1) NZ225654A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
FR2665834B1 (fr) * 1991-07-24 2001-02-23 Sandoz Sa Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
EP1034181B1 (en) * 1997-11-28 2006-01-11 Dainippon Sumitomo Pharma Co., Ltd. Crystalline amrubicin hydrochloride
WO2003035660A1 (fr) * 2001-10-23 2003-05-01 Sumitomo Chemical Company, Limited Stabilisation d'hydrochlorure d'amrubicine
KR101059715B1 (ko) * 2002-11-29 2011-08-29 다이닛본 스미토모 세이야꾸 가부시끼가이샤 안정화된 안트라사이클린계 화합물의 동결 건조 제제
CN100395255C (zh) * 2005-02-02 2008-06-18 江苏豪森药业股份有限公司 马来酸氨柔比星盐及其制备方法和用途
KR20070088447A (ko) * 2005-05-11 2007-08-29 시코르, 인크. 안정한 동결건조된 안트라사이클린 글리코시드
CA2762348A1 (en) 2009-05-27 2010-12-02 Hajimu Hirofuji Stabilized and lyophilized formulation of anthracycline compounds
EP2934449B1 (en) * 2012-12-19 2018-01-10 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
WO2016024369A1 (ja) * 2014-08-13 2016-02-18 テバ製薬株式会社 がん治療用医薬組成物
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
US4540695A (en) * 1981-08-12 1985-09-10 Sumitomo Chemical Co., Ltd. Aminonaphthacene derivatives and their use
JPS5976099A (ja) * 1982-10-22 1984-04-28 Sumitomo Chem Co Ltd アミノナフタセン誘導体とその製造方法
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
CA1324959C (en) 1993-12-07
FI883602A0 (fi) 1988-08-01
AU2042188A (en) 1989-02-09
ES2038763T3 (es) 1993-08-01
ATE71526T1 (de) 1992-02-15
KR890003791A (ko) 1989-04-18
NO175134B (no) 1994-05-30
EP0302729B1 (en) 1992-01-15
KR970000507B1 (ko) 1997-01-13
FI91483C (fi) 1994-07-11
US4952566A (en) 1990-08-28
EP0302729A1 (en) 1989-02-08
DE3867751D1 (de) 1992-02-27
AU609168B2 (en) 1991-04-26
NO175134C (no) 1994-09-07
NZ225654A (en) 1991-03-26
FI91483B (fi) 1994-03-31
NO883447D0 (no) 1988-08-03
DK436688A (da) 1989-02-06
GR3004330T3 (da) 1993-03-31
FI883602A (fi) 1989-02-06
JP2603480B2 (ja) 1997-04-23
JPS6440493A (en) 1989-02-10
DK173317B1 (da) 2000-07-17
NO883447L (no) 1989-02-06

Similar Documents

Publication Publication Date Title
DK436688A (da) Praeparat af anthracyclin og derivater deraf samt fremgangsmaade til fremstilling af dette
DK98695A (da) Fremgangsmåde til solubilisering af iiie-polyanioniske polysaccharider og fremgangsmåde til modificering af neutrale polysaccharider
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
DK205585D0 (da) Polysaccharidproteinkonjugat, fremgangsmaade til fremstilling deraf ogpraeparat omfattende et polysaccharidproteinkonjugat
DK502888A (da) Anvendelse af azithromycin og derivater deraf til fremstilling af antiprotozoale laegemidler
FI890068A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2-bis(aminometyyli)syklobutaani-platinakompleksien valmistamiseksi
DK135887A (da) Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK379987D0 (da) Forgrenede polycarbonater indeholdende methylen-bis-napthalenforbindelser, samt fremgangsmaader til deres fremstilling
DK188286A (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
DK0443471T3 (da) 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater
ATE134642T1 (de) Tylosin-derivate
EP0247848A3 (en) Water-compatible reducible compounds and their use in analytical compositions and methods
IT8820117A0 (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
DK0400637T3 (da) Præparat indeholdende FR115224-substans til parenteral administration
MA20852A1 (fr) Composes nouveaux et leurs preparations.
EP0357109A3 (en) Platinum-(ii)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action
DK621688D0 (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
DK251289A (da) Avermectinderivater
DK0454494T3 (da) Calicheamicinoner, derivater deraf og analoge dertil og fremgangsmåde til fremstilling af disse
DK39388A (da) Isoxazol-derivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne derivater
NO902405D0 (no) Vevplasminogenaktivatorderivat, dna-sekvens og ekspresjonsplasmid, samt fremgangsmaate for fremstilling av plasmidet.
DK587585D0 (da) 13 alfa-alkyl-17 beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser
NO885144D0 (no) Steroider med 19,11baa-brubinding, fremgangsmÿte for deres fremstilling og farmastiske preparater som inneholder d isse.
ES293035U (es) Marco bastidor para modulos invariables portamecanismos
PT90140A (pt) Processo para a preparacao de preparados para cintigrafia ossea contendo tc-99m-omega-alquilfosfinico-1-hidroxialcano-1,1-difosfonatos

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired